Skip to content
  • Home
  • Book Bag: 0 items (Full)
    • English
    • 日本語
    • 中文(简体)
    • 中文(繁體)
    • اللغة العربية
  • About
Advanced
  • COVID-19 infection in chronic...
  • Cite this
  • Text this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Add to Book Bag Remove from Book Bag
  • Permanent link

COVID-19 infection in chronic spontaneous urticaria treated with omalizumab: two case reports

Not available

Bibliographic Details
Published in:Dermatology Reports
Main Authors: Angelo Massimiliano D'Erme, Cristian Fidanzi, Marco Romanelli, Valentina Dini, Giovanni Bagnoni, Agata Janowska
Format: Article
Language:English
Published: PAGEPress Publications 2023-08-01
Subjects:
Chronic idiopathic urticaria
chronic spontaneous urticaria
omalizumab
COVID-19
therapy
Online Access:https://www.pagepress.org/journals/index.php/dr/article/view/9763
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://www.pagepress.org/journals/index.php/dr/article/view/9763

Similar Items

  • Omalizumab for the management of refractory chronic spontaneous urticaria
    by: P C Kathuria, et al.
    Published: (2022-01-01)
  • Does angioedema in patients with chronic spontaneous urticaria impact response to omalizumab?
    by: Thomas B. Casale, MD, et al.
    Published: (2024-08-01)
  • Retrospective analysis of the treatment of 61 cases of chronic spontaneous urticaria with omalizumab
    by: Shanshan OU, et al.
    Published: (2023-04-01)
  • Position statement for the use of omalizumab in the management of chronic spontaneous urticaria in Indian patients
    by: Kiran Godse, et al.
    Published: (2016-01-01)
  • Omalizumab's efficacy and safety against chronic spontaneous urticaria
    by: Öner Özdemir
    Published: (2023-08-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs